×
About 7,362 results

ALLMedicine™ Acromegaly Center

Research & Reviews  3,503 results

Anesthesia and airway management in a patient with acromegaly and tracheal compression ...
https://doi.org/10.1177/0300060521999541
The Journal of International Medical Research; Sun X, Chen C et. al.

Apr 21st, 2021 - A giant retrosternal goiter can lead to compression of vital organs in the mediastinum with high risk of acute cardiorespiratory decompensation. Additionally, patients with acromegaly are prone to developing severe airway obstruction and ventilati...

Impaired bone microarchitecture in premenopausal women with acromegaly: the possible ro...
https://doi.org/10.1210/clinem/dgab260
The Journal of Clinical Endocrinology and Metabolism; Silva PPB, Pereira RMR et. al.

Apr 19th, 2021 - Acromegaly can impair bone integrity, increasing the risk of vertebral fractures (VF). To evaluate the impact of isolated GH/IGF-I hypersecretion on bone turnover markers,Wnt inhibitors, BMD, microarchitecture, bone strength and vertebral fracture...

Soluble alpha klotho in acromegaly: Comparison to traditional markers of disease activity.
https://doi.org/10.1210/clinem/dgab257
The Journal of Clinical Endocrinology and Metabolism; Schweizer JROL, Schilbach K et. al.

Apr 17th, 2021 - Soluble alpha klotho (sαKL) has been linked to growth hormone (GH) action, but systematic evaluation and comparison to traditional biomarkers in acromegaly are lacking. To evaluate the potential of sαKL to aid classification of disease activity. R...

Acromegaly presenting with myelopathy due to ossification of posterior longitudinal lig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045308
BMC Musculoskeletal Disorders; Kamakura D, Fukutake K et. al.

Apr 15th, 2021 - Acromegaly is a rare disease caused by high serum levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), often originating from a pituitary adenoma. Spinal and peripheral joint abnormalities are caused by these hormonal hypersecre...

see more →

Guidelines  13 results

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) ...
https://doi.org/10.1016/j.numecd.2016.02.001
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Baroni MG, Giorgino F et. al.

Feb 25th, 2016 - Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic de...

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) ...
https://doi.org/10.1007/s40618-015-0404-6
Journal of Endocrinological Investigation; Baroni MG, Giorgino F et. al.

Dec 31st, 2015 - Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic de...

Acromegaly: an endocrine society clinical practice guideline.
https://doi.org/10.1210/jc.2014-2700
The Journal of Clinical Endocrinology and Metabolism; Katznelson L, Laws ER et. al.

Oct 30th, 2014 - The aim was to formulate clinical practice guidelines for acromegaly. The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), five experts in the field, and a methodologist. The authors received no...

Expert consensus document: A consensus on the medical treatment of acromegaly.
https://doi.org/10.1038/nrendo.2014.21
Nature Reviews. Endocrinology; Giustina A, Chanson P et. al.

Feb 25th, 2014 - In March 2013, the Acromegaly Consensus Group met to revise and update guidelines for the medical treatment of acromegaly. The meeting comprised experts skilled in the medical management of acromegaly. The group considered treatment goals covering...

American Association of Clinical Endocrinologists medical guidelines for clinical pract...
https://www.ncbi.nlm.nih.gov/pubmed/21846616
Endocrine Practice : Official Journal of the American Col... Katznelson L, Atkinson JL et. al.

Aug 23rd, 2011 - American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.|2011|Katznelson L,Atkinson JL,Cook DM,Ezzat SZ,Hamrahian AH,|diagnosis,therapy,standards,trends,...

see more →

Drugs  35 results see all →

Clinicaltrials.gov  3,671 results

Anesthesia and airway management in a patient with acromegaly and tracheal compression ...
https://doi.org/10.1177/0300060521999541
The Journal of International Medical Research; Sun X, Chen C et. al.

Apr 21st, 2021 - A giant retrosternal goiter can lead to compression of vital organs in the mediastinum with high risk of acute cardiorespiratory decompensation. Additionally, patients with acromegaly are prone to developing severe airway obstruction and ventilati...

Impaired bone microarchitecture in premenopausal women with acromegaly: the possible ro...
https://doi.org/10.1210/clinem/dgab260
The Journal of Clinical Endocrinology and Metabolism; Silva PPB, Pereira RMR et. al.

Apr 19th, 2021 - Acromegaly can impair bone integrity, increasing the risk of vertebral fractures (VF). To evaluate the impact of isolated GH/IGF-I hypersecretion on bone turnover markers,Wnt inhibitors, BMD, microarchitecture, bone strength and vertebral fracture...

Soluble alpha klotho in acromegaly: Comparison to traditional markers of disease activity.
https://doi.org/10.1210/clinem/dgab257
The Journal of Clinical Endocrinology and Metabolism; Schweizer JROL, Schilbach K et. al.

Apr 17th, 2021 - Soluble alpha klotho (sαKL) has been linked to growth hormone (GH) action, but systematic evaluation and comparison to traditional biomarkers in acromegaly are lacking. To evaluate the potential of sαKL to aid classification of disease activity. R...

Acromegaly presenting with myelopathy due to ossification of posterior longitudinal lig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045308
BMC Musculoskeletal Disorders; Kamakura D, Fukutake K et. al.

Apr 15th, 2021 - Acromegaly is a rare disease caused by high serum levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), often originating from a pituitary adenoma. Spinal and peripheral joint abnormalities are caused by these hormonal hypersecre...

see more →

News  125 results

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_6

Sep 15th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_2

Sep 15th, 2020 - Causes of excess IGF-I action can be divided into the following three categories: Release of primary GH excess from the pituitary Increased GHRH secretion or hypothalamic dysregulation Hypothetically, the excessive production of IGF-binding protei...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763

Sep 15th, 2020 - Gigantism refers to abnormally high linear growth due to excessive action of insulin-like growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the gr...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_3

Sep 15th, 2020 - Gigantism is extremely rare, with approximately 100 reported cases to date. Acromegaly is more common than gigantism, with an incidence of 3-4 cases per million people per year and a prevalence of 60 cases per million population. A claims-based an...

FDA Approves First Oral Somatostatin Analog for Acromegaly
https://www.staging.medscape.com/viewarticle/933087

Jun 28th, 2020 - The US Food and Drug Administration (FDA) has approved oral octreotide (Mycapssa, Chiasma) delayed-release capsules for the long-term maintenance treatment of patients with acromegaly who previously responded to and tolerated octreotide or lanreot...

see more →

Patient Education  15 results see all →